Albert Vilella, PhD.
@albertvilella.bsky.social
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, AI/ML in biotech // http://albertvilella.substack.com
Pinned
Guardant Health JPM26
Guardant Health presented at JP Morgan Healthcare 2026, and here we review their slide deck and give our highlights on the presentation.
albertvilella.substack.com
Here are my #JPM26 highlights on Substack:
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
Here are my #JPM26 highlights on Substack:
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
Guardant Health JPM26
Guardant Health presented at JP Morgan Healthcare 2026, and here we review their slide deck and give our highlights on the presentation.
albertvilella.substack.com
February 6, 2026 at 8:01 AM
Here are my #JPM26 highlights on Substack:
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
Guardant Health - albertvilella.substack.com/p/guardant-h...
Ginkgo Bioworks - albertvilella.substack.com/p/ginkgo-bio...
Recursion Pharma - albertvilella.substack.com/p/recursion-...
Twist Bio - albertvilella.substack.com/p/twist-bio-...
From Genomeweb:
MRD and MCED are the most promising Cancer Dx Technologies according to an Oncologist Survey by Labcorp
The survey of 152 oncologists found that Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) are the most promising tools for oncologists.
MRD and MCED are the most promising Cancer Dx Technologies according to an Oncologist Survey by Labcorp
The survey of 152 oncologists found that Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) are the most promising tools for oncologists.
February 6, 2026 at 7:57 AM
From Genomeweb:
MRD and MCED are the most promising Cancer Dx Technologies according to an Oncologist Survey by Labcorp
The survey of 152 oncologists found that Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) are the most promising tools for oncologists.
MRD and MCED are the most promising Cancer Dx Technologies according to an Oncologist Survey by Labcorp
The survey of 152 oncologists found that Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) are the most promising tools for oncologists.
Active equity funds, those that actively invest in stocks not just buying into indexes, have seen a record amount of withdrawals (outflows). People see a crash coming and are pulling their money out of the stock market.
December 19, 2025 at 1:14 PM
Active equity funds, those that actively invest in stocks not just buying into indexes, have seen a record amount of withdrawals (outflows). People see a crash coming and are pulling their money out of the stock market.
Another $3.5 M added by ark invest.
Is Recursion Pharma up for acquisition? [COPY] JPM25: Recursion $RXRX open.substack.com/pub/albertvi...
Is Recursion Pharma up for acquisition? [COPY] JPM25: Recursion $RXRX
Below is the piece I wrote a year ago for JPM Healthcare on Recursion Pharma.
open.substack.com
December 19, 2025 at 11:28 AM
Another $3.5 M added by ark invest.
Is Recursion Pharma up for acquisition? [COPY] JPM25: Recursion $RXRX open.substack.com/pub/albertvi...
Is Recursion Pharma up for acquisition? [COPY] JPM25: Recursion $RXRX
Below is the piece I wrote a year ago for JPM Healthcare on Recursion Pharma.
open.substack.com
December 18, 2025 at 2:51 PM
Is Recursion Pharma up for acquisition? [COPY] JPM25: Recursion $RXRX open.substack.com/pub/albertvi...
Ark Invest buys a few million dollars worth of Recursive Pharma $RXRX
December 18, 2025 at 9:09 AM
Ark Invest buys a few million dollars worth of Recursive Pharma $RXRX
.@andrew.diffuse.one on 2025 state of LLMs
December 17, 2025 at 6:09 PM
.@andrew.diffuse.one on 2025 state of LLMs
.@meta announced SAM Audio: an AI model that allows you to isolate and edit sound from complex audio mixtures. about.fb.com/news/2025/12...
Our New SAM Audio Model Transforms Audio Editing
We're introducing SAM Audio, a state-of-the-art AI model that enables you to segment sound.
about.fb.com
December 17, 2025 at 4:10 PM
.@meta announced SAM Audio: an AI model that allows you to isolate and edit sound from complex audio mixtures. about.fb.com/news/2025/12...
.@slavov-n.bsky.social on cell size vs cell count in the human body.
Lots of white blood cells in number, lots of adipocytes (fat) in volume.
Lots of white blood cells in number, lots of adipocytes (fat) in volume.
December 17, 2025 at 4:08 PM
.@slavov-n.bsky.social on cell size vs cell count in the human body.
Lots of white blood cells in number, lots of adipocytes (fat) in volume.
Lots of white blood cells in number, lots of adipocytes (fat) in volume.
Dislocation between oil and US interest rates in recent times
December 17, 2025 at 1:28 PM
Dislocation between oil and US interest rates in recent times
[COPY] JPM25 Exact Sciences $EXAS: this is my post from JPM Healthcare last year. What will JPM26 bring for Exact Sciences, recently acquired by Abbott? open.substack.com/pub/albertvi...
[COPY] JPM25 Exact Sciences $EXAS
What will 2026 bring for Exact Sciences?
open.substack.com
December 16, 2025 at 8:58 AM
[COPY] JPM25 Exact Sciences $EXAS: this is my post from JPM Healthcare last year. What will JPM26 bring for Exact Sciences, recently acquired by Abbott? open.substack.com/pub/albertvi...
From @semianalysis.com.web.brid.gy, Nvidia $NVDA acquires SchedMD, makers of SLURM, a widely used open source workload scheduler. Many AI companies such as Mistral, Thinking Machines, parts of Meta's FAIR division, university academic labs use SLURM.
December 16, 2025 at 8:52 AM
From @semianalysis.com.web.brid.gy, Nvidia $NVDA acquires SchedMD, makers of SLURM, a widely used open source workload scheduler. Many AI companies such as Mistral, Thinking Machines, parts of Meta's FAIR division, university academic labs use SLURM.
@rohitsingh8080.bsky.social USHER: Guiding Foundation Model Representations through Distribution Shifts
Aditya Pratapa, Purushothama Rao Tata, Rohit Singh
bioRxiv 2025.11.20.689462; doi: doi.org/10.1101/2025...
Aditya Pratapa, Purushothama Rao Tata, Rohit Singh
bioRxiv 2025.11.20.689462; doi: doi.org/10.1101/2025...
USHER: Guiding Foundation Model Representations through Distribution Shifts
Foundation models pre-trained on certain biological data modalities exhibit systematic representational biases when encountering out-of-distribution (OOD) data from new assays. The embedding drift lar...
doi.org
December 15, 2025 at 8:54 PM
@rohitsingh8080.bsky.social USHER: Guiding Foundation Model Representations through Distribution Shifts
Aditya Pratapa, Purushothama Rao Tata, Rohit Singh
bioRxiv 2025.11.20.689462; doi: doi.org/10.1101/2025...
Aditya Pratapa, Purushothama Rao Tata, Rohit Singh
bioRxiv 2025.11.20.689462; doi: doi.org/10.1101/2025...
.@weili from @blackrock on 2026 outlook
December 13, 2025 at 1:31 PM
.@weili from @blackrock on 2026 outlook
The posts by Michael Burry on @Substack have been one of the most exciting things happening this year. Lots to learn from someone who has been in the markets for a long time.
December 13, 2025 at 10:48 AM
The posts by Michael Burry on @Substack have been one of the most exciting things happening this year. Lots to learn from someone who has been in the markets for a long time.
A post by @artificialanlys on the new OpenAI chatGPT 5.2
December 12, 2025 at 1:59 PM
A post by @artificialanlys on the new OpenAI chatGPT 5.2
Notes about Substrate, the U.S. semiconductor startup that made headlines last month for claiming it can produce 100% Made-in-America chips comparable to TSMC’s — a bold goal in an industry dominated by entrenched players like TSMC and ASML.
December 11, 2025 at 8:12 PM
Notes about Substrate, the U.S. semiconductor startup that made headlines last month for claiming it can produce 100% Made-in-America chips comparable to TSMC’s — a bold goal in an industry dominated by entrenched players like TSMC and ASML.